You are here

Article info

Article menu
Download PDFPDF
Original article
Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis

Authors

  1. Correspondence to Dr Andrea Skrabl-Baumgartner, Department of Pediatrics, Medical University Graz, Graz 8036, Austria; andrea.skrabl-baumgartner{at}medunigraz.at
View Full Text

Citation

Skrabl-Baumgartner A, Seidel G, Langner-Wegscheider B, et al
Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis
Archives of Disease in Childhood 2019;104:246-250.

Publication history

  • Received February 27, 2018
  • Revised June 13, 2018
  • Accepted July 3, 2018
  • First published July 19, 2018.
Online issue publication 
August 07, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.